These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7031551)

  • 1. Naloxone-associated morbidity and mortality.
    Pallasch TJ; Gill CJ
    Oral Surg Oral Med Oral Pathol; 1981 Dec; 52(6):602-3. PubMed ID: 7031551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone: a word of caution.
    Burke DF; Dunwoody CJ
    Orthop Nurs; 1990; 9(4):44-6. PubMed ID: 2168031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone.
    Martin WR
    Ann Intern Med; 1976 Dec; 85(6):765-8. PubMed ID: 187095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
    McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
    Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of enteral naloxone for the reversal of opiate-induced constipation in the intensive care unit.
    Arpino PA; Thompson BT
    J Clin Pharm Ther; 2009 Apr; 34(2):171-5. PubMed ID: 19250137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone inhibits not only stress-induced analgesia but also sympathetic activation and baroreceptor-reflex sensitivity.
    Fechir M; Breimhorst M; Kritzmann S; Geber C; Schlereth T; Baier B; Birklein F
    Eur J Pain; 2012 Jan; 16(1):82-92. PubMed ID: 21745755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative pressure pulmonary edema following naloxone administration in a patient with fentanyl-induced respiratory depression.
    Horng HC; Ho MT; Huang CH; Yeh CC; Cherng CH
    Acta Anaesthesiol Taiwan; 2010 Sep; 48(3):155-7. PubMed ID: 20864067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fentanyl, naloxone, and clonidine on hemodynamics and plasma catecholamine levels in dogs.
    Flacke JW; Flacke WE; Bloor BC; Olewine S
    Anesth Analg; 1983 Mar; 62(3):305-13. PubMed ID: 6829930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narcotic antagonism by naloxone. Few side-effects after a short procedure?
    Magnusson J; Werner O; Carlsson C; Pettersson KI
    Anaesthesia; 1983 Feb; 38(2):103-7. PubMed ID: 6829875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone hydrochloride: a review.
    Goodrich PM
    AANA J; 1990 Feb; 58(1):14-6. PubMed ID: 2180244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist.
    Akil H; Mayer DJ; Liebeskind JC
    Science; 1976 Mar; 191(4230):961-2. PubMed ID: 1251210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissection of peripheral and central endogenous opioid modulation of systemic interleukin-1beta responses using c-fos expression in the rat brain.
    Buller KM; Hamlin AS; Osborne PB
    Neuropharmacology; 2005 Aug; 49(2):230-42. PubMed ID: 15993445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation.
    Leppert W; Zajaczkowska R; Wordliczek J
    Expert Opin Pharmacother; 2019 Apr; 20(5):511-522. PubMed ID: 30625013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a fixed-dose opioid agonist/antagonist on constipation in patients on long-term opioids for non-malignant pain unable to tolerate laxatives.
    Mehta V; Alaward S; Kuravinakop S; Nikolic S
    Pain Physician; 2014; 17(5):415-24. PubMed ID: 25247899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of morphine analgesia by lithium: role of peripheral and central opioid receptors.
    Johnston IN; Westbrook RF
    Behav Brain Res; 2004 May; 151(1-2):151-8. PubMed ID: 15084430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism by naloxone of narcotic-induced respiratory depression and analgesia.
    McGilliard KL; Takemori AE
    J Pharmacol Exp Ther; 1978 Nov; 207(2):494-503. PubMed ID: 30841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative cardiac contractile actions of six narcotic analgesics: morphine, meperidine, pentazocine, fentanyl, methadone and l-alpha-acetylmethadol (LAAM).
    Rendig SV; Amsterdam EA; Henderson GL; Mason DT
    J Pharmacol Exp Ther; 1980 Oct; 215(1):259-65. PubMed ID: 6109016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.
    Kim S; Wagner HN; Villemagne VL; Kao PF; Dannals RF; Ravert HT; Joh T; Dixon RB; Civelek AC
    J Nucl Med; 1997 Nov; 38(11):1726-31. PubMed ID: 9374341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate.
    Gan TJ; Ginsberg B; Glass PS; Fortney J; Jhaveri R; Perno R
    Anesthesiology; 1997 Nov; 87(5):1075-81. PubMed ID: 9366459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.